Evaluating Brexpiprazole for the Management of Behavioral and Psychological Symptoms of Dementia.

The article discusses three randomized controlled trials (RCT) which focused on the use of brexpiprazole to treat the behavioral and psychological symptoms of dementia (BPSD). Topics explored include the brexpiprazole dosage administered which demonstrated improvement in symptoms, the treatment-emergent adverse events recorded following treatment, and a comparison between brexpiprazole and other antipsychotic medications in terms of effectiveness in managing BPSD.